You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 16, 2025

Drug Price Trends for DENTAGEL


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for DENTAGEL

Average Pharmacy Cost for DENTAGEL

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
DENTAGEL 1.1% GEL 16571-0815-60 0.11304 GM 2025-04-23
DENTAGEL 1.1% GEL 64980-0307-60 0.11304 GM 2025-04-23
DENTAGEL 1.1% GEL 16571-0815-60 0.11117 GM 2025-03-19
DENTAGEL 1.1% GEL 64980-0307-60 0.11117 GM 2025-03-19
DENTAGEL 1.1% GEL 16571-0815-60 0.10662 GM 2025-02-19
DENTAGEL 1.1% GEL 64980-0307-60 0.10662 GM 2025-02-19
DENTAGEL 1.1% GEL 16571-0815-60 0.09202 GM 2025-01-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Periodontal Therapeutics: A Focus on DENTAGEL and Related Markets

Introduction to Periodontal Therapeutics

Periodontal therapeutics are treatments and medications designed to address periodontal diseases, such as gingivitis and periodontitis, which affect a significant portion of the global population. The market for these therapeutics is growing rapidly due to increasing awareness of oral health, technological advancements, and a rising geriatric population.

Global Market Size and Growth

The global periodontal therapeutics market was estimated at USD 872.8 million in 2023 and is projected to grow at a CAGR of 7.2% from 2024 to 2030. This growth is driven by the high prevalence of periodontal diseases, with severe cases affecting approximately 19% of the adult population worldwide, or over 1 billion cases[1].

Regional Market Analysis

North America

North America, particularly the U.S., dominates the market with a 37.7% share in 2023. This is due to the high prevalence of periodontal diseases, with approximately 42% of U.S. adults affected. Government initiatives and advancements in dental research and technology are also driving growth in this region[1].

Europe

Europe is another lucrative region, driven by a significant population base, including an aging demographic more prone to periodontal diseases. Germany, in particular, is expected to see growth due to its strong healthcare system and comprehensive dental care coverage[1].

Asia Pacific

The Asia Pacific region is anticipated to witness the fastest growth due to a large target population, high unmet clinical needs, and developing healthcare infrastructure. Countries like China and Japan are key drivers, with China's large population and Japan's rapidly aging population contributing to the market's growth[1].

Latin America and MEA

Latin America, especially Brazil, is expected to grow rapidly due to increasing awareness of oral health and hygiene. The Middle East and Africa (MEA) region also shows promise, driven by the high prevalence of periodontal diseases, although it is hindered by poor oral hygiene practices and inadequate access to dental care[1].

Market Drivers

  • Increasing Awareness of Oral Health: Growing awareness among the population about the importance of oral health is driving demand for periodontal therapeutics.
  • Technological Advancements: Innovations in dental research and technology are leading to more effective and innovative treatment options.
  • Aging Population: The rising geriatric population is more prone to periodontal diseases, increasing the demand for therapeutics.
  • Government Initiatives: Favorable government policies and reimbursement schemes are incentivizing individuals to seek treatment for periodontal diseases[1].

Competitive Landscape

The periodontal therapeutics market is competitive, with major players focusing on the development of new solutions. For instance, the University of Pennsylvania and the ADA Science & Research Institute received funding to study oral mucosa and its relation to gum disease, indicating a strong research focus in the industry[1].

Product-Specific Analysis: DENTAGEL

While specific data on DENTAGEL is not provided in the sources, we can infer its potential market performance based on the broader periodontal therapeutics market.

Market Positioning

DENTAGEL, as a product within the periodontal therapeutics market, would benefit from the overall growth trends in this sector. Its market positioning would depend on its efficacy, ease of use, and competitive pricing.

Price Projections

Given the lack of specific price data for DENTAGEL, we can look at the general trends in the periodontal therapeutics market. The market is expected to grow significantly, driven by increasing demand and technological advancements. Therefore, products like DENTAGEL are likely to see increased adoption and potentially higher pricing due to their value proposition in treating periodontal diseases.

Illustrative Statistics

  • Global Prevalence: Severe periodontal diseases affect approximately 19% of the adult population worldwide, or over 1 billion cases[1].
  • Market Growth: The global periodontal therapeutics market is projected to grow at a CAGR of 7.2% from 2024 to 2030[1].
  • Regional Dominance: North America accounted for 37.7% of the market share in 2023, driven by high prevalence and favorable government initiatives[1].

Expert Insights

"Periodontal diseases pose significant challenges to oral health globally. The growing awareness and technological advancements are driving the demand for effective therapeutics," says a dental health expert. "Products like DENTAGEL, if proven effective, could capture a significant share of this growing market."

Key Takeaways

  • The global periodontal therapeutics market is growing rapidly due to increasing awareness of oral health and technological advancements.
  • North America, Europe, and the Asia Pacific are key regions driving the market growth.
  • Products like DENTAGEL are likely to benefit from the overall market trends, provided they offer effective and innovative solutions.
  • The market is expected to continue growing, driven by a rising geriatric population and favorable government initiatives.

FAQs

Q: What is the current size of the global periodontal therapeutics market? A: The global periodontal therapeutics market was estimated at USD 872.8 million in 2023[1].

Q: What is the projected CAGR for the periodontal therapeutics market from 2024 to 2030? A: The market is projected to grow at a CAGR of 7.2% from 2024 to 2030[1].

Q: Which region dominates the periodontal therapeutics market? A: North America, particularly the U.S., dominates the market with a 37.7% share in 2023[1].

Q: What are the key drivers of the periodontal therapeutics market? A: Increasing awareness of oral health, technological advancements, an aging population, and favorable government initiatives are key drivers[1].

Q: How does the Asia Pacific region contribute to the periodontal therapeutics market? A: The Asia Pacific region is expected to witness the fastest growth due to a large target population, high unmet clinical needs, and developing healthcare infrastructure[1].

Sources

  1. Grand View Research: Periodontal Therapeutics Market Size & Share Report, 2030
  2. Bitget: Dent Price Prediction & Forecast for 2024 - 2050
  3. The Business Research Company: Dental Anesthesia Global Market Report 2024
  4. Data Bridge Market Research: Global Dental Periodontics Drug Market
  5. Changelly: Dent (DENT) Price Prediction 2024 2025 2026 2027 - 2030
Last updated: 2025-01-02

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.